Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - SUMOylation - MAGL - Insulin and Insulin-like Receptors
清除全部
- B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂
- B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B1036 MLN49245 CitationTarget: NAE|Ubiquitin-activating Enzyme E1|SUMOylationSummary: NAE抑制剂
- B2193 Mitiglinide Calcium中文名: 米格列奈钙Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B1296 Glibenclamide中文名: 格列本脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素生产调节剂
- A8534 Terfenadine中文名: 特非那定Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) ChannelsSummary: 组胺H1受体拮抗剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂